Ohio State-Duke spinoff Basking Biosciences raises $55M to test stroke treatment

"We are eager to advance our innovative pipeline and improve patient outcomes, ” CEO Richard Shea said in a news release.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2024 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news